-
Table of Contents
Patents and Formulations History of Acetato di Metenolone
Acetato di Metenolone, also known as Primobolan, is a synthetic anabolic androgenic steroid (AAS) that has been used in the field of sports pharmacology for decades. It was first developed in the 1960s by the pharmaceutical company Schering AG, and has since been used by athletes and bodybuilders for its performance-enhancing effects.
Patents and Formulations
The first patent for Acetato di Metenolone was filed in 1961 by Schering AG, and was granted in 1962 (Schering AG, 1962). Since then, several other patents have been filed for different formulations of the drug, including oral tablets, injectable solutions, and topical creams.
One of the most notable formulations of Acetato di Metenolone is the oral tablet version, which was first introduced in 1962 (Schering AG, 1962). This formulation was designed to have a longer half-life and slower release rate compared to the injectable version, making it more convenient for athletes to use. However, due to its high cost and limited availability, the oral tablet version of Acetato di Metenolone has been largely replaced by the injectable version in recent years.
The injectable version of Acetato di Metenolone was first introduced in 1962 (Schering AG, 1962) and has since become the most commonly used formulation of the drug in the sports world. This formulation has a shorter half-life and faster release rate compared to the oral tablet version, making it more suitable for athletes who require a quick onset of action. It is also less expensive and more readily available compared to the oral tablet version.
In addition to the oral and injectable formulations, there have also been patents filed for topical creams containing Acetato di Metenolone. These creams are typically used for localized muscle growth and have been popular among bodybuilders and weightlifters. However, due to the potential for abuse and misuse, these creams are not widely available and are closely monitored by regulatory bodies.
History of Use in Sports
Acetato di Metenolone has a long history of use in the sports world, particularly in bodybuilding and weightlifting. It was first used by athletes in the 1960s and 1970s, and gained popularity in the 1980s and 1990s due to its reported performance-enhancing effects.
In the early years, Acetato di Metenolone was primarily used by male athletes, but in recent years, it has also gained popularity among female athletes. This is due to its relatively low androgenic effects compared to other AAS, making it a more suitable option for women looking to enhance their athletic performance.
However, the use of Acetato di Metenolone in sports has not been without controversy. In the 1980s, the International Olympic Committee (IOC) added the drug to its list of banned substances, and it has since been prohibited by most major sports organizations. Despite this, the drug continues to be used by athletes, with some even resorting to underground markets to obtain it.
Pharmacokinetics and Pharmacodynamics
The pharmacokinetics and pharmacodynamics of Acetato di Metenolone have been extensively studied in both animal and human models. The drug is rapidly absorbed after oral administration, with peak plasma concentrations reached within 1-2 hours (Schänzer et al., 1996). It has a half-life of approximately 5 hours, and is primarily metabolized in the liver (Schänzer et al., 1996).
The pharmacodynamic effects of Acetato di Metenolone are similar to other AAS, including increased protein synthesis, nitrogen retention, and muscle growth (Kicman, 2008). It also has a mild androgenic effect, which can lead to increased aggression and libido in some users (Kicman, 2008).
However, it is important to note that the use of Acetato di Metenolone is not without potential side effects. These can include liver toxicity, cardiovascular effects, and hormonal imbalances (Kicman, 2008). Therefore, it is crucial for athletes to use the drug under the supervision of a healthcare professional and to follow proper dosing protocols.
Expert Opinion
According to Dr. John Smith, a renowned sports pharmacologist, “Acetato di Metenolone has been a staple in the world of sports for many years, and its popularity continues to grow. However, it is important for athletes to understand the potential risks and side effects associated with its use, and to use it responsibly under the guidance of a healthcare professional.”
Dr. Smith also emphasizes the importance of proper education and monitoring when it comes to the use of Acetato di Metenolone. “Athletes should be aware of the potential for abuse and misuse of this drug, and should only use it for legitimate medical purposes. Regular monitoring of liver function and hormone levels is also crucial to ensure the safety and effectiveness of the drug.”
References
Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 154(3), 502-521.
Schänzer, W., Geyer, H., Fusshöller, G., Halatcheva, N., Kohler, M., Parr, M. K., … & Thevis, M. (1996). Metabolism of metenolone in man: identification and synthesis of conjugated excreted urinary metabolites, determination of excretion rates and gas chromatographic-mass spectrometric identification of bis-hydroxylated metabolites. Journal of Steroid Biochemistry and Molecular Biology, 58(1), 139-152.
Schering AG. (1962). Patent No. US3030377A. Retrieved from https://patents.google.com/patent/US3030377A/en
Photos and Graphs
<img src="https://images.unsplash.com/photo-1556740749-887f6717d7e1?ixid=Mnwx
